Kalydeco (Vertex Pharmaceuticals Incorporated)
Welcome to the PulseAid listing for the Kalydeco drug offered from Vertex Pharmaceuticals Incorporated. This Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC],Chloride Channel Activation Potentiators [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Vertex Pharmaceuticals Incorporated |
| NON-PROPRIETARY NAME: | ivacaftor |
| SUBSTANCE NAME: | IVACAFTOR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC],Chloride Channel Activation Potentiators [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | GRANULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-03-23 |
| END MARKETING DATE: | 0000-00-00 |
Kalydeco HUMAN PRESCRIPTION DRUG Details:
| Item Description | Kalydeco from Vertex Pharmaceuticals Incorporated |
| LABELER NAME: | Vertex Pharmaceuticals Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2015-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51167-300_b8737c5a-6b1a-48a1-af69-b652becc7428 |
| PRODUCT NDC: | 51167-300 |
| APPLICATION NUMBER: | NDA207925 |
Other IVACAFTOR Pharmaceutical Manufacturers / Labelers:
